Clinical Trial Update: Propofol Versus Midazolam as Premedication for Preterm Neonates With Respiratory Distress Syndrome (RDS) [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 trial comparing propofol and midazolam as premedication for preterm neonates with respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Midazolam (Midazolam)
• PROPOFOL (Propofol)

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Respiratory Distress Syndrome | Phase 4 | Status: UNKNOWN